Tag

Acute Myelogenous Leukemia Archives | Carevive - cancer care management & patient engagement tools

CME

What’s New in Acute Myelogenous Leukemia?

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.75 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
CME

Geriatric Assessment in Older Patients with AML: Treatment Updates and Implications

Release date: October 17, 2018 
Expiration date: October 16, 2019 Estimated time to complete activity: 0.5 hours Acute myelogenous leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit…
Carevive
October 17, 2018
Resources

[On-Demand Video] Acute Myelogenous Leukemia: Treatment Updates and Implications for Older Patients

Note: This on-demand video is not available for CME/CNE credit. Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy…
Carevive
July 25, 2018